Werner Enterprises Announces Quarterly Dividend

OMAHA, Neb., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Werner Enterprises, Inc. (NASDAQ: WERN), one of the nation’s largest transportation and logistics companies, announced today that its Board of Directors declared a regular quarterly cash dividend of $.060 (6.0 cents) per common share payable to stockholders of record at the close of business on January 3, 2017. This dividend will be paid on January 17, 2017.

Werner Enterprises has paid a quarterly cash dividend to its stockholders every quarter since July 1987.

Werner Enterprises, Inc. was founded in 1956 and is a premier transportation and logistics company, with coverage throughout North America, Asia, Europe, South America, Africa and Australia. Werner maintains its global headquarters in Omaha, Nebraska and maintains offices in the United States, Canada, Mexico, China and Australia. Werner is among the five largest truckload carriers in the United States, with a diversified portfolio of transportation services that includes dedicated van, temperature-controlled and flatbed; medium-to-long-haul, regional and local van; and expedited services. The Werner Logistics portfolio includes freight management, truck brokerage, intermodal, and international services. International services are provided through Werner’s domestic and global subsidiary companies and include ocean, air and ground transportation; freight forwarding; and customs brokerage.

Werner Enterprises, Inc.’s common stock trades on the NASDAQ Global Select MarketSM under the symbol “WERN”. For further information about Werner, visit the company’s website at www.werner.com.

Contact: John J. Steele
Executive Vice President, Treasurer
and Chief Financial Officer
(402) 894-3036

You May Also Be Interested In

• Pied Piper Launches New Era of Continuous Retailer Performance Monitoring and Proactive Alerts
• Dr. Gary Lawton Warns Plastic Surgery Patients: Audit the Operating Room
• Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain